Less Vertebral Bone Mass after Treatment with Macitentan in Mice: A Pilot Study

<div><i>Vertebral bone mass in different groups</i> (a) MicroCT images of the transverse plane and H&amp;E staining of the coronal sections of the <svg height="12.3641pt" id="M5" style="vertical-align:-0.2064009pt" version="1.1" viewbox="-0.0498162 -12.1577 14.7256 12.3641" width="14.7256pt" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink"><g transform="matrix(.013,0,0,-0.013,0,0)"><path d="M153 550H386L412 615L406 623H120L82 318C104 327 142 338 184 338C294 338 347 275 347 187C347 112 305 39 221 39C160 39 119 71 97 89C88 97 80 96 71 90C59 80 50 67 49 57C48 45 52 36 66 23C80 9 123 -12 169 -12C221 -11 288 15 342 59C403 109 431 165 431 225C431 308 366 395 238 395C212 395 165 379 127 364L153 550Z"></path></g><g transform="matrix(.0091,0,0,-0.0091,6.24,-5.741)"><path d="M303 37L293 66C280 59 256 49 231 49S173 63 173 143V396H281C294 404 298 428 287 439H173V575L158 577L92 509V439H46L17 408L22 396H92V107C92 27 128 -12 192 -12C203 -12 218 -9 237 2L303 37Z"></path></g><g transform="matrix(.0091,0,0,-0.0091,9.125,-5.741)"><path d="M522 0V30C462 35 455 41 455 106V280C455 397 397 451 314 451C262 451 206 414 171 379V710C131 698 69 682 20 675V647C87 642 90 637 90 574V106C90 41 80 35 20 30V0H236V30C176 35 171 43 171 106V339C198 371 237 391 276 391C341 391 374 350 374 269V106C374 43 367 35 308 30V0H522Z"></path></g></svg> lumbar vertebral body showed fewer and thinner trabeculae (black triangle) in Treatment group compared to controls. (b) Quantitative analysis revealed significant lower BV/TV, Tb.N, and Tb.Th and higher Tb.Sp in Treatment group compared to controls (<svg height="6.01072pt" id="M6" style="vertical-align:-0.04980993pt" version="1.1" viewbox="-0.0498162 -5.96091 7.75925 6.01072" width="7.75925pt" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink"><g transform="matrix(.013,0,0,-0.013,0,0)"><path d="M471 153C471 170 463 194 452 212C400 220 373 229 322 255C373 281 400 290 452 298C463 316 471 339 471 357C456 366 431 371 410 370C377 329 356 310 308 279C311 336 317 364 336 413C326 432 310 451 294 459C279 451 262 432 252 413C271 364 277 336 280 279C232 310 211 329 178 370C157 371 132 367 117 357C117 340 125 316 136 298C188 290 215 281 266 255C215 229 188 220 136 212C125 194 117 171 117 153C132 144 157 139 178 140C211 181 232 200 280 231C277 174 271 146 252 97C262 78 278 59 294 51C309 59 326 78 336 97C317 146 311 174 308 231C356 200 377 181 410 140C431 139 456 143 471 153Z"></path></g></svg>p&lt;0.05, n=7 for Control group, n=8 for Treatment group. Con.: Control, Mac.: Macitentan, BV/TV: trabecular bone volume per tissue volume, Tb.N.: trabecular number, Tb.Th.: trabecular thickness, and Tb.Sp.: trabecular separation).</div>

BioMed Research International

fig2

Figure 2

Figure 2: Less Vertebral Bone Mass after Treatment with Macitentan in Mice: A Pilot Study 